Journal Francais D Ophtalmologie最新文献

筛选
英文 中文
Clinical validity of automated refraction with the Chronos binocular refraction system compared to standard refraction techniques
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2025-03-13 DOI: 10.1016/j.jfo.2025.104477
P.-J. Phelouzat, V. Gualino, K. Pierne
{"title":"Clinical validity of automated refraction with the Chronos binocular refraction system compared to standard refraction techniques","authors":"P.-J. Phelouzat, V. Gualino, K. Pierne","doi":"10.1016/j.jfo.2025.104477","DOIUrl":"10.1016/j.jfo.2025.104477","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the agreement of automated refraction by the Chronos device (Topcon Corporation, Tokyo, Japan) with standard refraction techniques.</div></div><div><h3>Methods</h3><div>This retrospective, single-center study recruited patients who underwent refraction with the Nidek ARK-1 autorefraction [Nidek Technologies, Gamagori, Japan] and manual subjective refraction (standard method group), followed by autorefraction and guided subjective refraction with the Chronos binocular refraction system [Topcon Corporation, Tokyo, Japan] (Chronos method group). Concordance rates were set based on mean absolute differences of refractive measurements. Bland-Altman analysis, non-parametric analysis and Pearson's correlation coefficient (<em>r</em>) were used to assess agreement between methods.</div></div><div><h3>Results</h3><div>In all, 361 eyes of 182 patients (mean age 37.4<!--> <!-->±<!--> <!-->17.5 years) were included. Slightly more myopic mean objective and subjective sphere (<em>P</em> <!-->=<!--> <!-->0.005; <em>P</em> <!--><<!--> <!-->0.001), cylinder (<em>P</em> <!-->=<!--> <!-->0.001; <em>P</em> <!--><<!--> <!-->0.001) and spherical equivalent (SE; <em>P</em> <!--><<!--> <!-->0.001 for both) values were observed with the Chronos method. No statistically significant differences were seen for objective and subjective J0 (<em>P</em> <!-->=<!--> <!-->0.947; <em>P</em> <!-->=<!--> <!-->0.312) and objective and subjective J45 (<em>P</em> <!-->=<!--> <!-->0.131; <em>P</em> <!-->=<!--> <!-->0.084) values. High concordance between methods (difference <!--> <!-->≤<!--> <!-->0.25 D) was greater for objective sphere (79.0%), cylinder (87.1%), and SE (71.7%), than for subjective measurements (65.7%, 80.8%, and 57.0%, respectively). The methods were strongly correlated for objective and subjective sphere (<em>r</em> <!-->=<!--> <!-->0.983, <em>P</em> <!--><<!--> <!-->0.001; <em>r</em> <!-->=<!--> <!-->0.971, <em>P</em> <!--><<!--> <!-->0.001, respectively) and for objective and subjective cylinder (<em>r</em> <!-->=<!--> <!-->0.936, <em>P</em> <!--><<!--> <!-->0.001; <em>r</em> <!-->=<!--> <!-->0.869, <em>P</em> <!--><<!--> <!-->0.001, respectively). Good agreement was observed between the two methods with low systematic bias and clinically acceptable mean differences.</div></div><div><h3>Conclusion</h3><div>The results showed good agreement and strong correlations between both methods, suggesting that the Chronos device can be a good alternative technique for refractive error screening in routine clinical practice.</div></div><div><h3>Objectif</h3><div>Évaluer la concordance de la réfraction automatisée par l’appareil Chronos (Topcon Corporation, Tokyo, Japon) avec les techniques de réfraction standard.</div></div><div><h3>Méthodes</h3><div>Cette étude rétrospective et monocentrique a recruté des patients qui ont subi une réfraction avec l’autoréfraction Nidek ARK-1 [Nidek Technologies, Gamagori, Japon] et une","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 4","pages":"Article 104477"},"PeriodicalIF":1.2,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143610186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Capsulotomie circulaire ou radiaire pour le traitement du capsulophimosis : quelle serait la meilleure option ?
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2025-03-13 DOI: 10.1016/j.jfo.2025.104479
A. Mounsif , A. Laalou , H. Ait Lhaj , M. Kriet , F. El Asri
{"title":"Capsulotomie circulaire ou radiaire pour le traitement du capsulophimosis : quelle serait la meilleure option ?","authors":"A. Mounsif , A. Laalou , H. Ait Lhaj , M. Kriet , F. El Asri","doi":"10.1016/j.jfo.2025.104479","DOIUrl":"10.1016/j.jfo.2025.104479","url":null,"abstract":"<div><h3>Introduction</h3><div>Le capsulophimosis est une complication postopératoire fréquente de la chirurgie de la cataracte, due à une métaplasie fibreuse des cellules épithéliales résiduelles. Il entraîne une constriction capsulaire, altérant la qualité visuelle et la stabilité de l’implant intraoculaire (IOL). La capsulotomie au laser Nd:YAG, réalisée selon les techniques circulaire ou radiaire, reste le traitement de référence.</div></div><div><h3>Objectif</h3><div>Comparer les résultats des capsulotomies circulaire et radiaire en termes de gain visuel, de complications postopératoires et de stabilité de l’IOL.</div></div><div><h3>Matériel et méthodes</h3><div>Étude prospective, randomisée et monocentrique menée sur 108 yeux (54 par technique) suivis sur six mois. Les paramètres étudiés incluaient la meilleure acuité visuelle corrigée (MAVC), la pression intraoculaire et les complications (débris capsulaires, dislocation de l’IOL).</div></div><div><h3>Résultats</h3><div>La méthode circulaire a permis un gain moyen de 3,2 lignes sur l’échelle ETDRS contre 2,6 lignes pour la méthode radiaire (<em>p</em> <!--><<!--> <!-->0,05). Bien qu’associée à un taux accru de débris capsulaires (9,2 %), elle n’a engendré aucune complication majeure. En revanche, la méthode radiaire a été liée à un risque de luxation partielle de l’IOL dans 3 cas (5,6 %).</div></div><div><h3>Conclusion</h3><div>La capsulotomie circulaire semble offrir de meilleurs résultats fonctionnels et une stabilité accrue de l’IOL par rapport à la méthode radiaire. Cependant, des études à plus grande échelle avec un suivi prolongé sont nécessaires pour confirmer ces observations.</div></div><div><h3>Introduction</h3><div>Capsular phimosis is a common postoperative complication of cataract surgery, resulting from fibrous metaplasia of residual epithelial cells. It leads to capsular contraction, which affects visual quality and the stability of the intraocular lens (IOL). Nd:YAG laser capsulotomy, performed using either circular or radial techniques, remains the standard treatment.</div></div><div><h3>Purpose</h3><div>To compare the outcomes of circular vs. radial capsulotomies in terms of visual gain, postoperative complications, and IOL stability.</div></div><div><h3>Materials and methods</h3><div>A prospective, randomized, single-center study was conducted on 108 eyes (54 per technique) followed for six months. The parameters evaluated included best corrected visual acuity (BCVA), intraocular pressure (IOP), and complications (capsular debris, IOL dislocation).</div></div><div><h3>Results</h3><div>The circular technique provided a mean gain of 3.2 lines on the ETDRS scale, compared to 2.6 lines for the radial technique (<em>P</em> <!--><<!--> <!-->0.05). Although associated with an increased rate of capsular debris (9.2%), no major complications occurred. In contrast, the radial technique was associated with a risk of partial IOL dislocation in 3 cases (5.6%).</div></div><div><","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 5","pages":"Article 104479"},"PeriodicalIF":1.2,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143610703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Glaucoma in cutis marmorata telangiectatica congenita syndrome].
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2025-03-12 DOI: 10.1016/j.jfo.2025.104480
W Amraoui, C Khodriss, M El Bahloul
{"title":"[Glaucoma in cutis marmorata telangiectatica congenita syndrome].","authors":"W Amraoui, C Khodriss, M El Bahloul","doi":"10.1016/j.jfo.2025.104480","DOIUrl":"https://doi.org/10.1016/j.jfo.2025.104480","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143624591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Iris metastasis from lung adenocarcinoma].
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2025-03-12 DOI: 10.1016/j.jfo.2025.104462
N Bouslous, A Daoui, M O Moustaine
{"title":"[Iris metastasis from lung adenocarcinoma].","authors":"N Bouslous, A Daoui, M O Moustaine","doi":"10.1016/j.jfo.2025.104462","DOIUrl":"https://doi.org/10.1016/j.jfo.2025.104462","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143624595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Butterfly wing pattern of acute iris depigmentation.
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2025-03-11 DOI: 10.1016/j.jfo.2025.104461
J V Piá Ludeña, A Lanzagorta Aresti, E Arias García
{"title":"Butterfly wing pattern of acute iris depigmentation.","authors":"J V Piá Ludeña, A Lanzagorta Aresti, E Arias García","doi":"10.1016/j.jfo.2025.104461","DOIUrl":"https://doi.org/10.1016/j.jfo.2025.104461","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143615473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Approche diagnostique et parcours thérapeutique de la dégénérescence maculaire liée à l’âge de type atrophique : recommandations de la Fédération France Macula
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2025-03-09 DOI: 10.1016/j.jfo.2025.104473
V. Capuano , O. Semoun , A. Combes , C.-J. Mehanna , H. Oubraham , E.H. Souied
{"title":"Approche diagnostique et parcours thérapeutique de la dégénérescence maculaire liée à l’âge de type atrophique : recommandations de la Fédération France Macula","authors":"V. Capuano , O. Semoun , A. Combes , C.-J. Mehanna , H. Oubraham , E.H. Souied","doi":"10.1016/j.jfo.2025.104473","DOIUrl":"10.1016/j.jfo.2025.104473","url":null,"abstract":"<div><div>La dégénérescence maculaire liée à l’âge (DMLA) atrophique représente une évolution défavorable de la maculopathie liée à l’âge, caractérisée par des lésions avancées de la rétine associées à des drusen, pseudodrusen ainsi qu’à des altérations de l’épithélium pigmentaire rétinien. Cette forme de DMLA se définit par un amincissement du tissu neuro-rétinien lié à la disparition des couches externes de la rétine. Notre objectif est de proposer des recommandations diagnostiques et thérapeutiques pour la prise en charge de la DMLA atrophique, à destination des ophtalmologistes, avec une approche standardisée, afin d’optimiser la gestion de cette pathologie. Le diagnostic de DMLA atrophique est fondé sur l’imagerie multimodale : la rétinographie couleur, les clichés en autofluorescence du fond d’œil (FAF) et la tomographie en cohérence optique structurelle (OCT) qui sont les examens de première intention pour évaluer la taille des lésions et l’épargne fovéolaire. L’OCT-angiographie (OCT-A) est utile afin de diagnostiquer une néovascularisation choroïdienne associée. Dans certains cas, le diagnostic différentiel peut nécessiter des examens complémentaires comme l’angiographie à la fluorescéine et/ou au vert d’indocyanine. L’évaluation de la fonction visuelle repose essentiellement sur la mesure de l’acuité visuelle. D’autres tests fonctionnels tels que la vitesse de lecture, la mesure de l’acuité visuelle en basse luminance (LLVA), la sensibilité aux contrastes ou la micropérimétrie présentent un intérêt certain, bien qu’ils ne soient pas encore utilisés en routine clinique. La prise en charge de cette pathologie est multidisciplinaire : elles nécessite une surveillance clinique régulière, un traitement médical, un soutien psychologique, une réhabilitation orthoptique et des aides visuelles optiques. Les associations de patients représentent un soutien non négligeable.</div></div><div><div>Atrophic age-related macular degeneration (AMD) represents a detrimental progression of age-related maculopathy, characterized by advanced retinal lesions associated with drusen and pseudodrusen as well as alterations in the outer retinal layers and RPE. It is characterized by a thinning of the neuroretinal tissue linked to the disappearance of the outer layers of the retina and the RPE. Our goal is to offer to ophthalmologists recommendations in the diagnosis and management of atrophic AMD with a standardized approach, in order to facilitate and optimize the management of this disease. The diagnosis of atrophic AMD is based on multimodal imaging; color fundus photography, autofluorescence images of the fundus (AFF) and structural optical coherence tomography (OCT) are the first-line examinations to assess lesion size and foveolar sparing. OCT-angiography (OCT-A) is useful in diagnosing associated choroidal neovascularization. At times, the differential diagnosis will require other complementary examinations, such as fluorescein and/or indocyanine green angi","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 4","pages":"Article 104473"},"PeriodicalIF":1.2,"publicationDate":"2025-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143579649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A retrospective analysis of presentation and outcomes in a cluster outbreak of non-occupational laser exposure retinopathy
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2025-03-09 DOI: 10.1016/j.jfo.2025.104470
M.A. Joglekar , C.M. Khare , G.A. Gadre , M.G. Dalvi , C.A. Khanwelkar
{"title":"A retrospective analysis of presentation and outcomes in a cluster outbreak of non-occupational laser exposure retinopathy","authors":"M.A. Joglekar , C.M. Khare , G.A. Gadre , M.G. Dalvi , C.A. Khanwelkar","doi":"10.1016/j.jfo.2025.104470","DOIUrl":"10.1016/j.jfo.2025.104470","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate and describe the clinical presentation and outcomes of a case series with possible retinal laser injury following recreational laser shows and assess their attributability to laser exposure.</div></div><div><h3>Design</h3><div>Multi-center case series.</div></div><div><h3>Subjects</h3><div>All consecutive eyes with reported laser exposure from recreational laser show and confirmed retinal injury presenting between May 2022 and April 2023.</div></div><div><h3>Methods</h3><div>Data were collected including demographics, details of laser exposure, prior ophthalmic or significant past medical history, clinical presentation including visual acuity, fundus photography, optical coherence tomography (OCT) or fundus fluorescein angiography (FFA) if available, treatment used, and follow-up and final outcomes in terms of visual acuity and complications, if any. Fundus photographs and OCT images were analyzed.</div></div><div><h3>Main outcome measures</h3><div>Demographics of the cohort, presenting and final visual acuity, morphology of retinal injury on fundus photographs and OCT images, complications if any, regression analysis to test connections to known events.</div></div><div><h3>Results</h3><div>The study included a total of 51 eyes of 51 patients, all of whom reported exposure to recreational laser shows. The mean LogMAR visual acuity at presentation was 1183 (SD 0.50). All the eyes had premacular hemorrhage of mean size 1.90 disc diameters (SD 1.29), while a dot of retinal whitening (“white spot”) was observed within the parafoveal area in 13 eyes (32.5%). Laser hyaloidotomy was performed in 54.9% of eyes, while 45.10% were managed conservatively. The majority of eyes [22, 78.57%] showed complete drainage immediately after hyaloidotomy, while partial drainage occurred in six eyes (21.43%). Only two eyes (4.26%) exhibited small residual hemorrhage at the end of the three-month period. Final mean LogMAR visual acuity was 0.123 (SD 0.20). Complications included RPE changes and epiretinal membrane formation. The incidence of cases correlated well with significant cultural events.</div></div><div><h3>Conclusion</h3><div>The presentation in all eyes was strongly suggestive of laser injury. Even though the outcomes were favorable, complications were not uncommon. We strongly recommend the immediate introduction of regulatory measures and establishment of a monitoring framework for laser shows in India. We propose referring to these injuries as “non-occupational laser exposure retinopathy”.</div></div><div><h3>Objectif</h3><div>Investiguer et décrire la présentation clinique et les résultats d’une série de cas de lésions rétiniennes possibles suite à des spectacles de laser récréatifs et évaluer leur attribuabilité à l’exposition au laser.</div></div><div><h3>Conception</h3><div>Série de cas multicentrique.</div></div><div><h3>Sujets</h3><div>Tous les yeux consécutifs présentant une exposition signalée au laser réc","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 4","pages":"Article 104470"},"PeriodicalIF":1.2,"publicationDate":"2025-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143580368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world comparison of efficacy and safety of XEN45 implant with phacoemulsification versus iStent inject® W with phacoemulsification
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2025-03-08 DOI: 10.1016/j.jfo.2025.104469
A.L. Mendoza-Moreira , M.T. Marcos-Parra , S. de Bari , J. Ezbakhe , E. España-Vera , M.C. Calatayud-Hernández , J.J. Pérez-Santonja
{"title":"Real-world comparison of efficacy and safety of XEN45 implant with phacoemulsification versus iStent inject® W with phacoemulsification","authors":"A.L. Mendoza-Moreira , M.T. Marcos-Parra , S. de Bari , J. Ezbakhe , E. España-Vera , M.C. Calatayud-Hernández , J.J. Pérez-Santonja","doi":"10.1016/j.jfo.2025.104469","DOIUrl":"10.1016/j.jfo.2025.104469","url":null,"abstract":"<div><h3>Purpose</h3><div>To compare iStent inject® W<!--> <!-->+<!--> <!-->phacoemulsification with XEN45 implant<!--> <!-->+<!--> <!-->phacoemulsification over 12 months in mild to moderate glaucoma patients needing cataract surgery at the Hospital General Universitario Dr. Balmis, Alicante, Spain.</div></div><div><h3>Methods</h3><div>Retrospective clinical cohort study. Consecutive patients who underwent phacoemulsification either combined with XEN45 implantation or iStent inject® W from 2020 to 2022 were included. The main outcome measure was surgical success at 12 months postoperatively. Intraocular pressure (IOP), number of antiglaucoma medications, intraoperative and postoperative complications, number of revision surgeries, use of the operating room and required visits were also evaluated.</div></div><div><h3>Results</h3><div>A total of 167 eyes were included in the study, with 101 eyes of 61 patients undergoing iStent<!--> <!-->+<!--> <!-->PHACO and 66 eyes of 46 patients undergoing XEN45<!--> <!-->+<!--> <!-->PHACO. The proportion of patients achieving a complete success (IOP<!--> <!-->≥<!--> <!-->5 and ≤ 18<!--> <!-->mmHg without medication) at the conclusion of the 12-month follow-up was 47.9% (35/73) in the iStent<!--> <!-->+<!--> <!-->PHACO and 48.2% (27/56) in the XEN45<!--> <!-->+<!--> <!-->PHACO surgery group, <em>P</em> <!-->=<!--> <!-->1.000. The mean (95% CI) IOP reduction at the conclusion of the study follow-up was –2.4 (–3.5 to –1.3<!--> <!-->mmHg, <em>P</em> <!--><<!--> <!-->0.001, iStent<!--> <!-->+<!--> <!-->PHACO) and –3.10 (–4.8 to –1.4<!--> <!-->mmHg, <em>P</em> <!--><<!--> <!-->0.001, XEN45<!--> <!-->+<!--> <!-->PHACO). The mean number of antiglaucoma medications was significantly reduced in both study groups. Rates of intraoperative complications (5 vs. 15.2%), postoperative complications (1 vs. 46.2%), reoperations (0 vs. 24.6%), mean number of operating room visits (1 vs. 1.41), and mean number of required postoperative visits (4.50 vs. 11.13) were all statistically significantly higher in the XEN45<!--> <!-->+<!--> <!-->PHACO group (< 0.001).</div></div><div><h3>Conclusions</h3><div>Both procedures achieved similar surgical success rates, with comparable reductions in IOP and the number of antiglaucoma medications. After one year, a modest IOP reduction of 10.83% was observed in the iStent group and 13.65% in the Xen group. However, the iStent inject® W demonstrated a better intraoperative and postoperative safety profile.</div></div><div><h3>Objectif</h3><div>L’objectif était de comparer l’iStent inject® W associé à une phacoémulsification avec l’implant XEN45 associé à une phacoémulsification sur une période de 12 mois chez des patients atteints de glaucome léger à modéré nécessitant une chirurgie de la cataracte à l’Hôpital General Universitario Dr Balmis, à Alicante, en Espagne.</div></div><div><h3>Méthodes</h3><div>Étude clinique rétrospective de cohorte. Des patients consécutifs ayant subi une phac","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 4","pages":"Article 104469"},"PeriodicalIF":1.2,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143580367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biometry combining Scheimpflug imaging and partial coherence interferometry versus standard partial coherence interferometry biometry
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2025-03-07 DOI: 10.1016/j.jfo.2025.104465
V.E.W.C.M. van Renterghem, F.-X. Crahay
{"title":"Biometry combining Scheimpflug imaging and partial coherence interferometry versus standard partial coherence interferometry biometry","authors":"V.E.W.C.M. van Renterghem, F.-X. Crahay","doi":"10.1016/j.jfo.2025.104465","DOIUrl":"10.1016/j.jfo.2025.104465","url":null,"abstract":"<div><h3>Purpose</h3><div>To compare measurements of mean keratometry (K), axial length (AL), Jackson first and second astigmatism vector (J0 and J45), astigmatism magnitude, white-to-white (WTW) diameter and anterior chamber depth (ACD) values between two biometers, the Pentacam® AXL and the IOL Master 500.</div></div><div><h3>Setting</h3><div>Public hospital in Belgium.</div></div><div><h3>Design</h3><div>Retrospective instrument reliability analysis.</div></div><div><h3>Methods</h3><div>Eyes of cataract or refractive lens exchange patients were examined preoperatively on a device combining Scheimpflug imaging and partial coherence interferometry (Pentacam® AXL) and a reference optical biometer (IOL Master 500). K, AL, J0, J45, astigmatism, WTW and ACD values were compared.</div></div><div><h3>Results</h3><div>Three hundred and twenty-eight eyes of 187 cataract or refractive lens exchange patients (mean age 68<!--> <!-->years) were examined preoperatively. Measurements of mean keratometry, axial length, ACD, white-to-white and astigmatism were significantly different (<em>P</em> <!--><<!--> <!-->0.05) between the two devices. Measurements of J0 and J45 did not significantly differ. Keratometry measurements with the Pentacam® AXL were significantly flatter than those measured with the IOL Master 500. Axial length measured with Pentacam® AXL was significantly greater when measured with the IOL Master 500, but this difference was not clinically relevant (0.015<!--> <!-->mm).</div></div><div><h3>Conclusions</h3><div>The Pentacam® AXL and the IOL Master 500 cannot be used interchangeably.</div></div><div><h3>Objectif</h3><div>Comparer les mesures de la kératométrie moyenne (K), de la longueur axiale (AL), du premier et du deuxième vecteur d’astigmatisme de Jackson (J0 et J45), de l’ampleur de l’astigmatisme, des mesures du blanc au blanc (WTW) et des valeurs de profondeur de la chambre antérieure (ACD) entre deux biomètres, le Pentacam® AXL et l’IOL Master 500.</div></div><div><h3>Lieu</h3><div>Hôpital public en Belgique.</div></div><div><h3>Conception</h3><div>Rétrospective, analyse de la fiabilité de l’instrument.</div></div><div><h3>Méthodes</h3><div>Les yeux de patients atteints de cataracte ou d’échange de lentilles réfractives ont été examinés en préopératoire sur un dispositif combinant une caméra Scheimpflug et l’interférométrie à cohérence partielle (Pentacam® AXL) et un biomètre optique de référence (IOL Master 500). Les valeurs de K, AL, J0, J45, d’astigmatisme, de WTW et d’ACD ont été comparées.</div></div><div><h3>Résultats</h3><div>Trois cent vingt-huit yeux de 187 patients ayant subi un échange de lentilles réfractives ou de cataracte (âge moyen de 68 ans) ont été examinés en préopératoire. Les mesures de la kératométrie moyenne, de la longueur axiale, de l’ACD, du blanc au blanc et de l’astigmatisme étaient significativement différentes (<em>p</em> <!--><<!--> <!-->0,05) pour les deux dispositifs. Les mesures pour J0 et J45 ne ","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 4","pages":"Article 104465"},"PeriodicalIF":1.2,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143563260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes in non-infectious uveitis patients treated with adalimumab in a tertiary eye care center
IF 1.2 4区 医学
Journal Francais D Ophtalmologie Pub Date : 2025-03-07 DOI: 10.1016/j.jfo.2025.104457
H. Sener , D. Gulmez Sevim , O. Temizyurek , M.T. Uludag , F. Ozer , C. Evereklioglu , Z. Beyza Akdeniz , A.B. Gunay Sener , F. Horozoglu
{"title":"Outcomes in non-infectious uveitis patients treated with adalimumab in a tertiary eye care center","authors":"H. Sener , D. Gulmez Sevim , O. Temizyurek , M.T. Uludag , F. Ozer , C. Evereklioglu , Z. Beyza Akdeniz , A.B. Gunay Sener , F. Horozoglu","doi":"10.1016/j.jfo.2025.104457","DOIUrl":"10.1016/j.jfo.2025.104457","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the efficacy of adalimumab (ADA) treatment in non-infectious uveitis and the effect of disease duration, age, and etiology on treatment outcome.</div></div><div><h3>Methods</h3><div>This retrospective study included patients with active non-infectious uveitis who were on ADA treatment with at least 3 months follow-up from a single tertiary care center. Uveitis type, any associated systemic disease, uveitis duration before ADA, duration of ADA treatment, best-corrected visual acuity (BCVA), anterior chamber cell (ACC) grade, vitritis grade, intraocular pressure (IOP) values, central macular thickness (CMT), fundus fluorescein angiography (FFA) score, complications and relapse rate were recorded.</div></div><div><h3>Results</h3><div>A total of 146 eyes of 77 patients (women<!--> <!-->=<!--> <!-->41, men<!--> <!-->=<!--> <!-->36) were included in the analysis. The mean age was 25.1<!--> <!-->±<!--> <!-->15.7 years. BCVA showed no significant improvement overall (+0.08, <em>P</em> <!-->=<!--> <!-->0.059) following ADA treatment. A weak negative correlation was found between the change in BCVA from baseline to final follow-up and disease duration before initiating ADA (r<!--> <!-->=<!--> <!-->−0.22, <em>P</em> <!-->=<!--> <!-->0.005). ACC and vitritis grade decreased significantly (−0.50, <em>p</em> <!--><<!--> <!-->0.001; −0.51, <em>P</em> <!--><<!--> <!-->0.001; respectively). The decrease in CMT was not significant (−18.6, <em>P</em> <!-->=<!--> <!-->0.390). Twenty patients (25.9%) experienced a relapse during treatment, and the mean relapse time was 24.9 months (95%CI: 21.0–28.9). Eleven (14.1%) of the patients required systemic corticosteroids as bridge therapy before ADA treatment and to suppress relapse while on ADA treatment. The mean dose of methylprednisolone decreased from 55.2<!--> <!-->±<!--> <!-->20.3<!--> <!-->mg to 12.3<!--> <!-->±<!--> <!-->18.0<!--> <!-->mg, and corticosteroids were discontinued in 7 of these patients.</div></div><div><h3>Conclusion</h3><div>ADA effectively controls intraocular inflammation and maintains visual stability in patients with non-infectious uveitis. Although BCVA did not show a statistically significant improvement overall, initiating ADA treatment early was correlated with better visual outcomes in some patients, particularly those who began treatment shortly after their disease onset. The corticosteroid burden was reduced.</div></div><div><h3>Objectif</h3><div>Évaluer l’efficacité du traitement par l’adalimumab (ADA) dans l’uvéite non infectieuse et l’effet de la durée de la maladie, de l’âge et de l’étiologie sur les résultats du traitement.</div></div><div><h3>Méthodes</h3><div>Cette étude rétrospective a inclus des patients atteints d’uvéite non infectieuse active sous traitement ADA avec un suivi d’au moins 3 mois dans un seul centre tertiaire. Le type d’uvéite, toute maladie systémique associée, la durée de l’uvéite avant l’ADA, la durée du traitement ADA","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 4","pages":"Article 104457"},"PeriodicalIF":1.2,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143562335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信